PEGylated Nanocarriers for Systemic Delivery
In this chapter, we outline the protocols for PEGylation of some drug carriers, such as dendrimer, polymeric nanoparticles, liposomes, for systemic delivery. PEGylation simply refers to the modification of particle surface by covalently grafting, entrapping, or adsorbing PEG chains of vivid length. However, limitation of simple adsorption being easy displacement of the coating layer in vivo, covalent mode for PEGylation of nanoparticles is mostly preferred, and outlined herein. Derivatization and activation of polyethylene glycol is an important step during PEGylation and its chemistry chiefly relies on availability as well as type of functional groups on carrier periphery. A summarized set of protocols for PEGylation of widely explored nanocarriers for systemic delivery is presented.
- MicroRNA Northern Blotting, Precursor Cloning, and Ago2-Improved RNA Interference
- Feeder Layers: Co-culture with Nonneoplastic Cells
- Mesoporous Silicon Particles for Sustained Gene Silencing
- Detecting Mechanisms of Acquired BRAF Inhibitor Resistance in Melanoma
- Use of the Polymerase Chain Reaction Technique to Detect the t(14;18) Translocation in Lymphoid Tissue
- Detection of the FIP1L1-PDGFRA Fusion in Idiopathic Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia
- Stability and Ubiquitination of the Tumor Suppressor Protein p53
- High-Throughput Technology: Green Fluorescent Protein to Monitor Cell Death
- Phosphatidylinositol 4-Kinase Assay in Ovarian Carcinoma Cells
- Karyotyping Lymph Node Biopsies in Non-Hodgkins Lymphoma